Biopharma Asia

March/April 2018 | Volume 7 Issue 2

---

Advances and Challenges in Vaccine Development and Manufacture

Tony D’Amore, Vice-President, Global Product Research & Development Sanofi Pasteur

---

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Director Development Analytics Roche Diagnostics GmbH, Germany

---

Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...

Bonnie K. Shum, Engineer II (Global Biologics MSAT) Genentech Inc., A member of the Roche...

---

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Associate Principal Scientist Ian Ashworth, Associate Principal Scientist A...

---

Development and Implementation of Process Analytical Technology (PAT) Systems in the Bioph...

Sameer Talwar1, Benoit Igne2, Juan Aon3, Dave Stevenson3, Janice Fernandez3, Diana Ritz3, ...

---

Is automation the disruption pharma R&D needs?

Barbara Paldus, PhD, Vice President and General Manager, Finesse, a part of Thermo Fisher ...

---